Initial experience with Imacor hTEE-guided management of patients following transplant and mechanical circulatory support.

Authors

Christopher KangFollow
Hitoshi Hirose, Thomas Jefferson UniversityFollow
Harold Hasting
Follow

Document Type

Article

Publication Date

Fall 11-1-2012

Comments

This article has been peer reviewed. It is the authors' final version prior to publication in ICU Director

August 22, 2012.

The published version is available at DOI:10.1177/1944451612456703. Copyright © Sage

Abstract

We reviewed an initial experience using a miniaturized transesophageal echocardiography (TEE) probe (ImaCor, Garden City, NY) with 3 patients in whom Imacor hTEE intervention was used as a point of care device to manage extracorporeal membrane oxygenation cannula placement, cardiac hemodynamics, and post-op cardiac pathophysiology. The management of transplant or mechanical circulatory support (MCS) patients is especially challenging: transplanted hearts pose unique pathophysiological challenges, and MCS significantly alters pressure-volume-flow relationships. Real-time “hemodynamic” TEE (hTEE) can help provide effective management by direct visualization of cardiac filling and function and help guide hemodynamic management. In our initial experience, hTEE can provide point-of-care management following transplant or MCS.

Recommended Citation

Kang, Christopher; Hirose, Hitoshi; Hasting, Harold; and , "Initial experience with Imacor hTEE-guided management of patients following transplant and mechanical circulatory support." (2012). Department of Cancer Biology Faculty Papers. Paper 31.
https://jdc.jefferson.edu/cbfp/31